Paper36960800
Effect of tenofovir-based HIV pre-exposure prophylaxis against HBV infection in men who have sex with men.
Mizushima D and 9 others. Hepatology, 2023. Cited by 27 papers, by iCite.
Cite this record
ConductScience Library. Effect of tenofovir-based HIV pre-exposure prophylaxis against HBV infection in men who have sex with men. Papers, record 36960800. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/36960800
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Effect of tenofovir-based HIV pre-exposure prophylaxis against HBV infection in men who have sex with men.
- PubMed
Topics11
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| HIV Infections | Major topic |
| Pre-Exposure Prophylaxis | Major topic |
| Anti-HIV Agents | Major topic |
| Sexual and Gender Minorities | Major topic |
| Sexually Transmitted Diseases | Major topic |
| Male | |
| Humans | |
| Tenofovir | |
| Hepatitis B virus | |
| Homosexuality, Male | |
| Hepatitis B Surface Antigens |
Source PubMed
Comments and corrections3
PubMed's comments and corrections, NLM's own indexing: retractions first, then expressions of concern, errata and updates, and comments last.
| Kind | PMID | Title | In Papers | Source |
|---|---|---|---|---|
| Comment in | 36938876 | Preventing 2 viral infections with 1 tablet. | https://conductscience.org/library/papers/36938876 | PubMed |
| Comment in | 37560991 | Reply: Effect of tenofovir-based HIV pre-exposure prophylaxis against HBV infection in men who have sex with men. | https://conductscience.org/library/papers/37560991 | PubMed |
| Comment in | 37738208 | Letter to the Editor: Effect of tenofovir-based HIV pre-exposure prophylaxis against HBV infection in men who have sex with men. | https://conductscience.org/library/papers/37738208 | PubMed |
Cited by15
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 27 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42683110 | Clinically Relevant Risk of Hepatitis B Virus Infection and Reactivation in People With HIV After Withdrawal of Anti-HBV-Active Antiretroviral Therapy in Japan. | Open Forum Infect Dis | 2026 | https://conductscience.org/library/papers/42683110 | PubMed |
| 42541296 | Hepatitis B virus outcomes in people with HIV after cessation of tenofovir-containing antiretroviral therapy: a systematic review and meta-analysis. | EClinicalMedicine | 2026 | https://conductscience.org/library/papers/42541296 | PubMed |
| 42499158 | Vaccination Coverage and Prevention Counselling for Vaccine-Preventable STIs Among HIV PrEP Users in São Paulo, Brazil: A Retrospective Cohort Study. | J Int AIDS Soc | 2026 | https://conductscience.org/library/papers/42499158 | PubMed |
| 41657849 | The hepatitis B care cascade among key populations towards global elimination: a systematic review and meta-analysis. | Lancet Reg Health West Pac | 2026 | https://conductscience.org/library/papers/41657849 | PubMed |
| 41452251 | Brief Report: Hepatitis B Vaccination Histories in Persons With HIV Needing Revaccination. | J Acquir Immune Defic Syndr | 2026 | https://conductscience.org/library/papers/41452251 | PubMed |
| 41408032 | Hepatitis A to E in People with HIV: A Virus-Specific Review of Prevention and Treatment. | Infect Dis Ther | 2026 | https://conductscience.org/library/papers/41408032 | PubMed |
| 41264590 | Serology change-based clinical interpretation of indeterminate serostatus post-hepatitis B virus infection in people living with HIV. | PLoS One | 2025 | https://conductscience.org/library/papers/41264590 | PubMed |
| 40612765 | HIV PrEP programmes as a framework for diagnosing and treating HBV infection in adolescents and young adults in KwaZulu-Natal, South Africa. | J Virus Erad | 2025 | https://conductscience.org/library/papers/40612765 | PubMed |
| 40523694 | Use of dual antiretroviral therapy in individuals with different serological patterns for hepatitis B: What are the risks? What are the clinical implications? | HIV Med | 2025 | https://conductscience.org/library/papers/40523694 | PubMed |
| 40287745 | The role of tenofovir-based HIV pre-exposure prophylaxis in preventing HBV infection among men who have sex with men: insights from China. | Infect Dis Poverty | 2025 | https://conductscience.org/library/papers/40287745 | PubMed |
| 39118019 | Prevalence and factors associated with hepatitis B susceptibility among men who sex with men on HIV pre-exposure prophylaxis in Northeastern Brazil: a cross-sectional study. | BMC Infect Dis | 2024 | https://conductscience.org/library/papers/39118019 | PubMed |
| 38596493 | Overview of the immunological mechanisms in hepatitis B virus reactivation: Implications for disease progression and management strategies. | World J Gastroenterol | 2024 | https://conductscience.org/library/papers/38596493 | PubMed |
| 38444112 | What does the scale-up of long-acting HIV pre-exposure prophylaxis mean for the global hepatitis B epidemic? | J Int AIDS Soc | 2024 | https://conductscience.org/library/papers/38444112 | PubMed |
| 38205796 | Hepatitis B Care Continuum Models-Data to Inform Public Health Action. | Public Health Rep | 2024 | https://conductscience.org/library/papers/38205796 | PubMed |
| 37627273 | Chronic Hepatitis B Infection: New Approaches towards Cure. | Biomolecules | 2023 | https://conductscience.org/library/papers/37627273 | PubMed |
Genes2
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| HBE1 | 3046 | PubTator's text mining | https://conductscience.org/library/genes/3046 | NCBI Gene |
| KRT88P | 85348 | PubTator's text mining | https://conductscience.org/library/genes/85348 | NCBI Gene |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- References
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/36960800
GET https://conductscience.org/api/papers/v1/36960800/authors